This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
health care sector is seen to experience an unprecedented level of competition. Through all this, competitiveintelligence professionals will surely be pushed hard to generate much-needed insights. Executive Profile: Arnold DuBell, Associate Competitive and Strategic Intelligence Director at Novartis.
The COVID-19 pandemic has ushered in a seismic shift in the pharmaceutical industry. An increasing number of pharma professionals are relying on marketintelligence platforms to stay on top of these movements while providing the tools they need to devise a business or investment strategy.
While the United States manufacturing sector took a hit from COVID-19-spawned disruptions, it is important to note that the industry churns out the goods needed to sustain the needs and wants of the world’s largest consumer market. Anupama Pokharna Senior Market, CI Manager Western Digital. As of 2019, there were some 12.8
The right to challenge assumptions (A) An internal market analyst should be expected to challenge internal assumptions that are not robust. The analyst should be drawing on a variety of both primary and secondary intelligence. A source of current intelligence to find new alliances, new partnerships, innovations, and new opportunities.
To survive in today’s fast-moving and always-evolving market landscape, every business needs competitiveintelligence (CI)—comprehensive knowledge about your competitors and how your company stacks up. CI allows you to track competitor behavior and glean the insights you need to create competitive advantages.
Our report details this shift across various sectors, including Banking and Finance, Consumer Products, Food and Beverage, Healthcare and Pharmaceutical, Media and Entertainment, Retail, Technology, Transportation, and Travel and Hospitality. On the contrary, it indicates that many brands bring their consumer insight efforts in-house.
Contify, an AI-enabled market and competitiveintelligence solutions provider, announced today that it has successfully deployed its platform to generate customized daily competitiveintelligence reports for a leading pharma company focused on the development of novel drugs to treat rare diseases. About Contify.
Department of State (DOS), and commercial clients in the pharmaceutical, financial services and education sectors. Datastrong enhanced Smartronix’s cloud capabilities and expanded solutions in enterprise analytics, data science, and data engineering and management. Datastrong also brought new federal clients within the U.S.
Expert networks are a critical tool for marketintelligence and are leveraged by professionals to gain firsthand knowledge of specialized industries, companies, and markets. Calculate the return on investment (ROI) of your marketintelligence by using our ROI calculator.
In fact, most marketintelligence platforms lack access to this form of intel, not only leaving blind spots in your research, but also a window for you to overlook lucrative market opportunities. What are the latest profitability and market size figures for pharmaceutical drug distribution?
AlphaSense, a leading AI-based marketintelligence platform , provides Expert Insights alongside an extensive universe of private, public, and premium content. A fully realized M&A research strategy incorporates the power of Expert Insights and an all-in-one marketintelligence platform to maximize return on investment (ROI).
This guide will compare 12 of the top competitor analysis tools on the market today, highlighting factors you need to know about to choose the right one: key features, limitations, capabilities, cost, and more. It enables a granular understanding of competitive landscapes, customer shifts, and sector-specific trends.
2 Next, we grouped pharmaceutical sponsors/collaborators by their Scrip 100 industry rankings into two groups: top 20 pharma and all other pharma. Our Approach to this Analysis: We started by analyzing pharma-sponsored clinical trials, 1 initiated between 2018 and 2022, for only unapproved primary immuno-oncology (IO) drugs.
The Value: AlphaSense is an AI-powered search engine for marketintelligence. And with Stream in AlphaSense, users can leverage expert perspectives against insights derived from our extensive and ever-growing universe of content, gaining a 360 view on any market, industry, or trend.
Competitiveintelligence (CI) has evolved beyond simple website monitoring and social media listening. Between unpredictable external events with ambiguous market impacts, consolidation of market cap into fewer stocks, and complicated geopolitical factors, competitiveintelligence is more complex than ever before.
Competitiveintelligence (CI) has evolved beyond simple website monitoring and social media listening. Between unpredictable external events with ambiguous market impacts, consolidation of market cap into fewer stocks, and complicated geopolitical factors, competitiveintelligence is more complex than ever before.
By Benjamin Gilad In two previous posts I featured the relevance of Porters insights to CompetitiveIntelligence professionals struggling with ad hoc information requests and few or no frameworks to think about the big picture. I wonder- do these attitudes affect European CEOs use of competitiveintelligence as well?
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content